T1	intervention 20 41	Calendula officinalis
T2	condition 59 87	radiation-induced dermatitis
T4	eligibility 369 412	women undergoing breast cancer radiotherapy
T5	No-of-participants 425 428	271
T6	No-of-participants 453 455	82
T7	outcome-Measure 497 593	prevalence of acute radiation-induced dermatitis (RTOG grade 2+) assessed at multiple skin sites
T8	No-of-participants 757 759	81
T9	intervention-participants 792 794	40
T10	control-participants 810 812	41
T11	outcome 863 914	prevalence of radiation-induced dermatitis grade 2+
T12	intervention-value 938 941	53%
T13	control-value 958 961	62%
T3	control 241 268	standard of care (Sorbolene
